Matthew Spinelli
Overview
Explore the profile of Matthew Spinelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
266
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah P, Spinelli M, Irungu E, Kabuti R, Ngurukiri P, Babu H, et al.
AIDS Behav
. 2024 Aug;
28(11):3836-3849.
PMID: 39136824
Pre-exposure prophylaxis (PrEP) is highly effective at reducing HIV acquisition. We aimed to estimate usage of oral-PrEP, and factors associated with adherence among female sex workers (FSWs) in Nairobi, Kenya,...
2.
Hickey M, Grochowski J, Mayorga-Munoz F, Oskarsson J, Imbert E, Spinelli M, et al.
J Acquir Immune Defic Syndr
. 2024 Mar;
96(3):280-289.
PMID: 38534179
Background: Early evidence suggests long-acting injectable cabotegravir and rilpivirine (LA-CAB/RPV) may be beneficial for people with HIV (PWH) who are unable to attain viral suppression (VS) on oral therapy. Limited...
3.
Martinson T, Nwogu-Attah J, Spinelli M, Gandhi M
Lancet HIV
. 2024 Mar;
11(5):e282-e283.
PMID: 38461845
No abstract available.
4.
Spinelli M, Gandhi M
Expert Rev Mol Diagn
. 2024 Feb;
24(3):169-175.
PMID: 38353417
Introduction: Although effective antiretroviral and pre-exposure prophylaxis/PrEP regimens are available globally, adherence challenges persist. Objective measures of adherence can both measure adherence accurately and can be used to drive interventions....
5.
Stewart J, Oware K, Donnell D, Violette L, Odoyo J, Soge O, et al.
N Engl J Med
. 2023 Dec;
389(25):2331-2340.
PMID: 38118022
Background: Doxycycline postexposure prophylaxis (PEP) has been shown to prevent sexually transmitted infections (STIs) among cisgender men and transgender women, but data from trials involving cisgender women are lacking. Methods:...
6.
Spinelli M, Gandhi M, Riva A
Curr Opin HIV AIDS
. 2023 May;
18(3):117-118.
PMID: 37144612
No abstract available.
7.
van Zyl G, Jennings L, Kellermann T, Nkantsu Z, Cogill D, Van Schalkwyk M, et al.
AIDS
. 2022 Oct;
36(14):2057-2062.
PMID: 36305182
Objective: Access to viral load measurements is constrained in resource-limited settings. A lateral flow urine tenofovir (TFV) rapid assay (UTRA) for patients whose regimens include TFV offers an affordable approach...
8.
Johnson K, Okochi H, Arreguin M, Watabe J, Glidden D, Chattopadhyay A, et al.
Clin Infect Dis
. 2022 Oct;
76(5):930-933.
PMID: 36253952
We found that urine tenofovir (TFV) levels >1500 ng/mL strongly predict virologic suppression among people with human immunodeficiency virus taking tenofovir alafenamide (odds ratio, 5.66; 95% confidence interval, 1.59-20.14; P...
9.
Conroy A, McKenna S, Ruark A, Neilands T, Spinelli M, Gandhi M
AIDS Behav
. 2022 May;
26(11):3551-3562.
PMID: 35507094
Couple relationships can be leveraged to improve adherence to antiretroviral therapy (ART), but few studies have identified relationship factors to target in interventions in sub-Saharan Africa. We conducted a cross-sectional...
10.
Jennings L, Kellermann T, Spinelli M, Nkantsu Z, Cogill D, Van Schalkwyk M, et al.
AIDS Res Hum Retroviruses
. 2021 Nov;
38(6):455-462.
PMID: 34779228
The high cost of viral load (VL) testing limits its use for antiretroviral therapy (ART) adherence support. A low-cost lateral flow urine tenofovir (TFV) rapid assay predicts pre-exposure prophylaxis breakthroughs,...